Completed PHASE3 INTERVENTIONAL 6-arm NCT00002529

Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer (12-93)

Adjuvant Therapy for Post/Perimenopausal Patients With Node Positive Breast Cancer Who Are Suitable for Endocrine Therapy Alone.

Sponsor: ETOP IBCSG Partners Foundation

Conditions Breast Cancer

Interventions cyclophosphamide doxorubicin hydrochloride epirubicin hydrochloride tamoxifen citrate toremifene

Updated 7 times since 2017 Last updated: Apr 3, 2013 Started: May 31, 1993 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Breast Cancer and is currently completed. ETOP IBCSG Partners Foundation leads this study, which shows 7 recorded versions since 1993 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Oct 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Oct 2022 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ETOP IBCSG Partners Foundation

Data source: ETOP IBCSG Partners Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Auckland, New Zealand , Aviano, Italy , Basel, Switzerland , Bern, Switzerland , Brescia, Italy , Cape Town, South Africa , Carlton South, Australia , Gothenburg (Goteborg), Sweden , Lausanne, Switzerland and 10 more locations